IMPACT OF BLADDER NECK INVOLVEMENT AND POSITIVE URINE CYTOLOGY IN SUBSTRATIFYING INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTS BASED ON THE PREDICTION OF HIGH-RISK RECURRENCE

被引：0
|
作者：
Fukushima, Hiroshi
Toide, Masahiro
Fukuda, Shohei
Moriyama, Shingo
Yasuda, Yosuke
Uehara, Sho
Kijima, Toshiki
Yoshida, Soichiro
Yokoyama, Minato
Ishioka, Junichiro
Matsuoka, Yoh
Saito, Kazutaka
Fujii, Yasuhisa
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP43-19
引用
收藏
页码：E626 / E626
页数：1
相关论文
共 50 条
  • [21] Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
    Rianne J. M. Lammers
    Jan C. M. Hendriks
    O. Rodriguez Faba Rodriguez Faba
    Wim P. J. Witjes
    Joan Palou
    J. Alfred Witjes
    World Journal of Urology, 2016, 34 : 173 - 180
  • [22] Pembrolizumab monotherapy for high-risk, non-muscle-invasive bladder cancer
    Rentsch, Cyrill A.
    Hayoz, Stefanie
    Cathomas, Richard
    LANCET ONCOLOGY, 2021, 22 (09): : E379 - E379
  • [23] Cigarette Smoking Status at Diagnosis and Recurrence in Intermediate-risk Non-muscle-invasive Bladder Carcinoma Reply
    Serretta, Vincenzo
    UROLOGY, 2013, 81 (02) : 281 - 282
  • [24] Treatment and survival in patients with recurrent high-risk non-muscle-invasive bladder cancer
    Chamie, Karim
    Ballon-Landa, Eric
    Daskivich, Timothy J.
    Bassett, Jeffrey C.
    Lai, Julie
    Hanley, Jan M.
    Konety, Badrinath R.
    Litwin, Mark S.
    Saigal, Christopher S.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (01) : 20.e9 - 20.e17
  • [25] Recurrence- and progression-free survival in intermediate-risk non-muscle-invasive bladder cancer: the impact of conditional evaluation and subclassification
    Kohada, Yuki
    Hayashi, Tetsutaro
    Hsi, Ryan S.
    Yukihiro, Kazuma
    Sentani, Kazuhiro
    Goto, Keisuke
    Inoue, Shogo
    Ohara, Shinya
    Teishima, Jun
    Kajiwara, Mitsuru
    Nishisaka, Takashi
    Yasui, Wataru
    Black, Peter C.
    Matsubara, Akio
    BJU INTERNATIONAL, 2021, 127 (04) : 473 - 485
  • [26] Bladder Epicheck® for surveillance in high-risk non-muscle-invasive bladder cancer: Initial experience
    Velasco, J. Cano
    Pujol, L. Polanco
    Cortes, J. C. Moreno
    Puentedura, A. Lafuente
    Fernandez, C. Hernandez
    ACTAS UROLOGICAS ESPANOLAS, 2023, 47 (08): : 471 - 473
  • [27] Re: Prediction Model for Recurrence Probabilities after Intravesical Chemotherapy in Patients with Intermediate-Risk Non-Muscle-Invasive Bladder Cancer, Including External Validation
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2017, 198 (03): : 482 - 482
  • [28] Previous Bladder Cancer History in Patients with High-Risk, Non-muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History
    Mitrakas, Lampros P.
    Zachos, Ioannis V.
    Tzortzis, Vassileios P.
    Gravas, Stavros A.
    Rouka, Erasmia C.
    Dimitropoulos, Konstantinos I.
    Vandoros, Gerasimos P.
    Karatzas, Anastasios D.
    Melekos, Michael D.
    Papavassiliou, Athanasios G.
    CANCER RESEARCH AND TREATMENT, 2015, 47 (03): : 495 - 500
  • [29] Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
    Grabe-Heyne, Kristin
    Henne, Christof
    Mariappan, Paramananthan
    Geiges, Gotz
    Poehlmann, Johannes
    Pollock, Richard F.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] NEW PREDICTIVE SCORING MODEL FOR RECURRENCE INCORPORATING BLADDER NECK INVOLVEMENT IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER
    Waseda, Yuma
    Inoue, Masaharu
    Ito, Masaya
    Kijima, Toshiki
    Yoshida, Soichiro
    Yokoyama, Minato
    Ishioka, Junichiro
    Matsuoka, Yoh
    Saito, Kazutaka
    Kihara, Kazunori
    Fujii, Yasuhisa
    JOURNAL OF UROLOGY, 2017, 197 (04): : E172 - E172
12345